These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 11585344)

  • 1. Osteoclast inhibitory peptide 2 inhibits osteoclast formation via its C-terminal fragment.
    Choi SJ; Kurihara N; Oba Y; Roodman GD
    J Bone Miner Res; 2001 Oct; 16(10):1804-11. PubMed ID: 11585344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parathyroid hormone stimulates TRANCE and inhibits osteoprotegerin messenger ribonucleic acid expression in murine bone marrow cultures: correlation with osteoclast-like cell formation.
    Lee SK; Lorenzo JA
    Endocrinology; 1999 Aug; 140(8):3552-61. PubMed ID: 10433211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of the functional domain of osteoclast inhibitory peptide-1/hSca.
    Koide M; Kurihara N; Maeda H; Reddy SV
    J Bone Miner Res; 2002 Jan; 17(1):111-8. PubMed ID: 11771657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osteocalcin fragment in bone matrix enhances osteoclast maturation at a late stage of osteoclast differentiation.
    Ishida M; Amano S
    J Bone Miner Metab; 2004; 22(5):415-29. PubMed ID: 15316862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteoclast inhibitory peptide-1 (OIP-1) inhibits measles virus nucleocapsid protein stimulated osteoclast formation/activity.
    Shanmugarajan S; Youssef RF; Pati P; Ries WL; Rao DS; Reddy SV
    J Cell Biochem; 2008 Jul; 104(4):1500-8. PubMed ID: 18348201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell-to-Cell adhesion via intercellular adhesion molecule-1 and leukocyte function-associated antigen-1 pathway is involved in 1alpha,25(OH)2D3, PTH and IL-1alpha-induced osteoclast differentiation and bone resorption.
    Okada Y; Morimoto I; Ura K; Watanabe K; Eto S; Kumegawa M; Raisz L; Pilbeam C; Tanaka Y
    Endocr J; 2002 Aug; 49(4):483-95. PubMed ID: 12402981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CytokineRegulation and the signaling mechanism of osteoclast inhibitory peptide-1 (OIP-1/hSca) to inhibit osteoclast formation.
    Koide M; Maeda H; Roccisana JL; Kawanabe N; Reddy SV
    J Bone Miner Res; 2003 Mar; 18(3):458-65. PubMed ID: 12619930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of human asparaginyl endopeptidase (legumain) as an inhibitor of osteoclast formation and bone resorption.
    Choi SJ; Reddy SV; Devlin RD; Menaa C; Chung H; Boyce BF; Roodman GD
    J Biol Chem; 1999 Sep; 274(39):27747-53. PubMed ID: 10488118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Depletion of CD4 and CD8 T lymphocytes in mice in vivo enhances 1,25-dihydroxyvitamin D3-stimulated osteoclast-like cell formation in vitro by a mechanism that is dependent on prostaglandin synthesis.
    Grcević D; Lee SK; Marusić A; Lorenzo JA
    J Immunol; 2000 Oct; 165(8):4231-8. PubMed ID: 11035056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Basic fibroblast growth factor inhibits osteoclast formation induced by 1alpha,25-dihydroxyvitamin D(3) through suppressing the production of osteoclast differentiation factor.
    Nakagawa N; Yasuda H; Yano K; Mochizuki Si; Kobayashi N; Fujimoto H; Yamaguchi K; Shima N; Morinaga T; Higashio K
    Biochem Biophys Res Commun; 1999 Nov; 265(1):45-50. PubMed ID: 10548488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reciprocal gene expression of osteoclastogenesis inhibitory factor and osteoclast differentiation factor regulates osteoclast formation.
    Nagai M; Sato N
    Biochem Biophys Res Commun; 1999 Apr; 257(3):719-23. PubMed ID: 10208850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deflazacort increases osteoclast formation in mouse bone marrow culture and the ratio of RANKL/OPG mRNA expression in marrow stromal cells.
    Chung H; Kang YS; Hwang CS; Moon IK; Yim CH; Choi KH; Han KO; Jang HC; Yoon HK; Han IK
    J Korean Med Sci; 2001 Dec; 16(6):769-73. PubMed ID: 11748360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of high phosphate concentration on osteoclast differentiation as well as bone-resorbing activity.
    Kanatani M; Sugimoto T; Kano J; Kanzawa M; Chihara K
    J Cell Physiol; 2003 Jul; 196(1):180-9. PubMed ID: 12767054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibroblastic stromal cells express receptor activator of NF-kappa B ligand and support osteoclast differentiation.
    Quinn JM; Horwood NJ; Elliott J; Gillespie MT; Martin TJ
    J Bone Miner Res; 2000 Aug; 15(8):1459-66. PubMed ID: 10934644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Annexin II stimulates RANKL expression through MAPK.
    Li F; Chung H; Reddy SV; Lu G; Kurihara N; Zhao AZ; Roodman GD
    J Bone Miner Res; 2005 Jul; 20(7):1161-7. PubMed ID: 15940368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired osteoclast formation in bone marrow cultures of Fgf2 null mice in response to parathyroid hormone.
    Okada Y; Montero A; Zhang X; Sobue T; Lorenzo J; Doetschman T; Coffin JD; Hurley MM
    J Biol Chem; 2003 Jun; 278(23):21258-66. PubMed ID: 12665515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human trabecular bone-derived osteoblasts support human osteoclast formation in vitro in a defined, serum-free medium.
    Atkins GJ; Kostakis P; Welldon KJ; Vincent C; Findlay DM; Zannettino AC
    J Cell Physiol; 2005 Jun; 203(3):573-82. PubMed ID: 15573398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nitric oxide regulates receptor activator of nuclear factor-kappaB ligand and osteoprotegerin expression in bone marrow stromal cells.
    Fan X; Roy E; Zhu L; Murphy TC; Ackert-Bicknell C; Hart CM; Rosen C; Nanes MS; Rubin J
    Endocrinology; 2004 Feb; 145(2):751-9. PubMed ID: 14563699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of osteoclastogenesis by gap junction communication.
    Matemba SF; Lie A; Ransjö M
    J Cell Biochem; 2006 Oct; 99(2):528-37. PubMed ID: 16639710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cloning and identification of human Sca as a novel inhibitor of osteoclast formation and bone resorption.
    Choi SJ; Devlin RD; Menaa C; Chung H; Roodman GD; Reddy SV
    J Clin Invest; 1998 Oct; 102(7):1360-8. PubMed ID: 9769328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.